Produkty 93772-31-7

CAS 93772-31-7 występuje w naszej ofercie pod nazwami: Neogambogic Acid, Neogambogic acid/ 99.38% (existing batch purity), Neogambogic acid, (Z)-4-((1S,3aR,5S,11R,14aS)-8,9-Dihydroxy-2,2,11-trimethyl-13-(3-methylbut-2-en-1-yl)-11-(4-methylpent-3-en-1-yl)-4,7-dioxo-2,3a,4,5,7,9,10,11-octahydro-1H-1,5-methanofuro[3,2-g]pyrano[3,2-b]xanthen-3a-yl)-2-methylbut-2-enoic acid, 99%. Oferty producentów: TRC, TargetMol, GLPBio, Biosynth, BLDpharm. Dostępne opakowania: 25mg, 1mg, 5mg, 10mg, 50mg, 100mg, 20mg, 0,1g.

Neogambogic Acid
TRC, Biosynth
  • opakowanie: 25mg, 0,1g, 0,25g, 0,5g
  • Warianty: 5
Zobacz produkt
Neogambogic acid/ 99.38% (existing batch purity)
TargetMol
  • opakowanie: 1mg, 5mg, 10mg, 25mg
  • Warianty: 6
od 485,65
Zobacz produkt
Neogambogic acid
GLPBio
  • opakowanie: 10mg, 20mg, 5mg
  • Warianty: 3
od 929,36
Zobacz produkt
(Z)-4-((1S,3aR,5S,11R,14aS)-8,9-Dihydroxy-2,2,11-trimethyl-13-(3-methylbut-2-en-1-yl)-11-(4-methylpent-3-en-1-yl)-4,7-dioxo-2,3a,4,5,7,9,10,11-octahydro-1H-1,5-methanofuro[3,2-g]pyrano[3,2-b]xanthen-3a-yl)-2-methylbut-2-enoic acid, 99%
BLDpharm
  • opakowanie: 10mg, 25mg, 50mg, 100mg
  • Warianty: 4
od 686,45
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(E)-4-[10,12-dihydroxy-8,21,21-trimethyl-5-(3-methylbut-2-enyl)-8-(4-methylpent-3-enyl)-14,18-dioxo-3,7,20-trioxahexacyclo[15.4.1.02,15.02,19.04,13.06,11]docosa-4(13),5,11,15-tetraen-19-yl]-2-methylbut-2-enoic acid (CAS 93772-31-7) to związek chemiczny o wzorze sumarycznym C38H46O9 i masie molowej 646.8 g/mol. Nazwa systematyczna IUPAC: (E)-4-[10,12-dihydroxy-8,21,21-trimethyl-5-(3-methylbut-2-enyl)-8-(4-methylpent-3-enyl)-14,18-dioxo-3,7,20-trioxahexacyclo[15.4.1.02,15.02,19.04,13.06,11]docosa-4(13),5,11,15-tetraen-19-yl]-2-methylbut-2-enoic acid. InChIKey: BLDWFKHVHHINGR-FYJGNVAPSA-N.

Dane identyfikacyjne
Wzór sumarycznyC38H46O9
Masa molowa646.8 g/mol
Nazwa IUPAC(E)-4-[10,12-dihydroxy-8,21,21-trimethyl-5-(3-methylbut-2-enyl)-8-(4-methylpent-3-enyl)-14,18-dioxo-3,7,20-trioxahexacyclo[15.4.1.02,15.02,19.04,13.06,11]docosa-4(13),5,11,15-tetraen-19-yl]-2-methylbut-2-enoic acid
InChIKeyBLDWFKHVHHINGR-FYJGNVAPSA-N
SMILESCC(=CCCC1(CC(C2=C(C3=C(C(=C2O1)CC=C(C)C)OC45C6CC(C=C4C3=O)C(=O)C5(OC6(C)C)C/C=C(\C)/C(=O)O)O)O)C)C

Dane obliczone przez PubChem (NCBI)

Synonimy: Neogambogic acid, Neo-gambogic acid, 2-Dioleoyl-sn-glycero-3-phosphoethanolamine, orb1220670
Izomery (ten sam wzór sumaryczny)
4-[12,16-dihydroxy-8,21,21-trimethyl-5-(3-methylbut-2-enyl)-8-(4-methylpent-3-enyl)-14,18-dioxo-3,7,20-trioxahexacyclo[15.4.1.02,15.02,19.04,13.06,11]docosa-4(13),5,9,11-tetraen-19-yl]-2-methylbut-2-enoic acid C38H46O9
(Z)-4-[(1S,2S,8R,15R,16S,17S,19R)-12,16-dihydroxy-8,21,21-trimethyl-5-(3-methylbut-2-enyl)-8-(4-methylpent-3-enyl)-14,18-dioxo-3,7,20-trioxahexacyclo[15.4.1.02,15.02,19.04,13.06,11]docosa-4(13),5,9,11-tetraen-19-yl]-2-methylbut-2-enoic acid C38H46O9
(Z)-4-[(1S,2S,8S,15S,16S,17S,19R)-12,16-dihydroxy-8,21,21-trimethyl-5-(3-methylbut-2-enyl)-8-(4-methylpent-3-enyl)-14,18-dioxo-3,7,20-trioxahexacyclo[15.4.1.02,15.02,19.04,13.06,11]docosa-4(13),5,9,11-tetraen-19-yl]-2-methylbut-2-enoic acid C38H46O9